Scarica l'app Stockscreener
4.93
1.20%
-0.06
Dopo l'orario di chiusura:
4.85
-0.08
-1.62%
Evoke Pharma Inc Borsa (EVOK) Ultime notizie
What machine learning models say about Evoke Pharma Inc.July 2025 Decliners & Fast Exit and Entry Strategy Plans - Newser
Will Volume Confirm Reversal in Evoke Pharma Inc.July 2025 Market Mood & Fast Gain Stock Trading Tips - 선데이타임즈
Using data filters to optimize entry into Evoke Pharma Inc.2025 Analyst Calls & Consistent Growth Equity Picks - Newser
Evoke Pharma Inc. stock trendline breakdown2025 Volatility Report & Smart Money Movement Alerts - Newser
Why Evoke Pharma Inc. stock attracts strong analyst attentionWeekly Stock Report & Technical Analysis for Trade Confirmation - Newser
Is Evoke Pharma Inc. trending in predictive chart modelsConsistent Profit Signals with AI Models - Newser
Using RSI to spot recovery in Evoke Pharma Inc.Consistent Return Setup with Exit Strategy - Newser
How sentiment analysis helps forecast Evoke Pharma Inc.Buy Strategy Review With Performance Summary - Newser
Can a trend reversal in Evoke Pharma Inc. lead to recoveryFree Real Market Momentum Signal Generator - Newser
Tools to monitor Evoke Pharma Inc. recovery probabilityIntelligent Trade Forecast With AI Analytics - Newser
Published on: 2025-08-11 01:03:10 - Newser
Is Evoke Pharma Inc. a Top Dividend Stock to Watch in 2025Earnings Based Stock Performance Forecast - Newser
Top Risks to Consider Before Buying Evoke Pharma Inc. StockGrowth Summary Based on Market Positioning - Newser
Evoke Pharma (EVOK) to Release Quarterly Earnings on Tuesday - Defense World
Will Evoke Pharma Inc. stock go up in YEARFastest Growing Stocks to Watch - thegnnews.com
Real time scanner hits for Evoke Pharma Inc. explainedHigh Probability Trade Outcome Prediction - Newser
Evoke Pharma Inc expected to post a loss of 30 cents a shareEarnings Preview - TradingView
Reviewing Sol-Gel Technologies (NASDAQ:SLGL) and Evoke Pharma (NASDAQ:EVOK) - Defense World
Evoke Pharma's GIMOTI Patent Extended to 2038 Through New Patent Issuance - AInvest
Evoke Pharma's GIMOTI Patent Extended To 2038 Following New Patent Issuance - Nasdaq
Evoke Pharma announces issuance of new U.S. patent for GIMOTI - TipRanks
Evoke Pharma Secures New U.S. Patent for GIMOTI® - TipRanks
Evoke Pharma Announces Issuance of New U.S. Patent for GIMOTI Wi - GuruFocus
Evoke Pharma's Extended Market Exclusivity for GIMOTI: A Strategic IP and Regulatory Triumph for Long-Term Growth - AInvest
Evoke Pharma Announces Issuance Of New U.S. Patent For Gimoti With Extended Exclusivity To Late 2038 - TradingView
Evoke Pharma, Inc. Announces New U.S. Patent for GIMOTI® with Extended Market Exclusivity to November 2038 - Quiver Quantitative
Evoke Pharma extends GIMOTI patent protection until 2038 - Investing.com
Evoke Pharma extends GIMOTI patent protection until 2038 By Investing.com - Investing.com Canada
GIMOTI Gastroparesis Treatment Secures 2-Year Patent Extension, Strengthening Market Position Through 2038 - Stock Titan
Applying chart zones and confluence areas to Evoke Pharma Inc.Watchlist Generator for Smart Money Signals - Newser
What makes Evoke Pharma Inc. stock price move sharplyPattern Breakout Prediction for Short Term - Newser
Visualizing Evoke Pharma Inc. stock with heatmapsSecure Buy Strategy Based on Risk Parameters - Newser
Elliott Wave Theory Predicts Pullback in Evoke Pharma Inc.Optimized Watchlist With Daily Adjustments Launched - beatles.ru
How does Evoke Pharma Inc. compare to its industry peersBuild a diversified portfolio for stability - Jammu Links News
What analysts say about Evoke Pharma Inc. stockHigh-octane gains - Jammu Links News
Is it the right time to buy Evoke Pharma Inc. stockMaximize your investment portfolio’s performance - Jammu Links News
When is Evoke Pharma Inc. stock expected to show significant growthExplosive portfolio gains - Jammu Links News
Can momentum traders help lift Evoke Pharma Inc.Technical Confirmation System with Signal Alerts - Newser
How does Evoke Pharma Inc. generate profit in a changing economyBuild wealth faster with expert stock selection - Jammu Links News
How volatile is Evoke Pharma Inc. stock compared to the marketOutperformance with explosive growth - Jammu Links News
4.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):